Trial Profile
The Relationship Between Direct Acting Antiviral Treatment Effect and Myeloid-Derived Suppressor Cells and NK Cells Activity in Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Daclatasvir/sofosbuvir (Primary) ; Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Jun 2017 New trial record